Skip to main content
Fig. 1 | Breast Cancer Research

Fig. 1

From: Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance

Fig. 1

Strength, Weakness, Opportunity and Threat (SWOT) analysis for systematic immunohistochemistry in DCIS. Routine assessment of hormone receptor status and HER2 protein expression by systematic immunohistochemical analysis in DCIS could increase interobserver concordance of DCIS grading. HER2 status may be used to personalize treatment, with de-escalation of therapy in HER2-negative DCIS patients

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us